Approvals/TGA/LUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL (10mg/mL) solution for injection vial

Approved

STANDARD

LUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL (10mg/mL) solution for injection vial

Approval Id: c05edd4cc72182b1
Product Name: LUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL (10mg/mL) solution for injection vial
Artg Id: 148325
Artg Name: LUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL solution for injection vial
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2008-11-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/81261cdc97e6e5f483af59e5c4c48e23.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/21ee801642d6bf4d4565f233d7e7409a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

c05edd4cc72182b1

Type

Standard